Buy Aevi Genomic Medicine Stock | GNMX Stock Price & Latest News | Public
GNMX

Aevi Genomic Medicine

$0.00 (0.00%)Today

    About GNMX

    Aevi Genomic Medicine, Inc. is a clinical stage biopharmaceutical company, which engages in finding treatments for rare and orphan diseases. Its research and development efforts leverage an internal genomics platform and an ongoing collaboration with the Center for Appl...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.04
    -0.08
    -0.12
    Q4 2019

    Expected EPS
    Q4 2019

    -$0.12

    Actual EPS
    Q4 2019

    Stats

    Market Cap$12,89M
    Volume
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$0.35
    1 Year Low$0.11
    Open
    High
    Low

    Buy any stock with any amount of money.

    Download the App
    Download the app